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Abstract
Introduction Impact on sexual function has received little
attention in the medical literature for a long time. Because
of the site of insertion of permanent tension free vaginal
tape (TVT) the G spot might be affected or the tape might
interfere with arousal and sensory stimulation. Recent
studies have reported varying degrees of sexual impairment
after TVT insertion ranging from 0% to 15% including
dyspareunia.
Aim The aim of this study was to evaluate sexual function
before and after suburethral sling removal due to postop-
erative female de novo dyspareunia. As a secondary
outcome, general patients’ satisfaction with their overall
continence situation was assessed.
Patients and methods Between December 2005 and
December 2007, we included 18 female patients who
complained of de novo dyspareunia after suburethral sling
insertion for urinary stress incontinence. All patients filled
in an FSFI questionnaire prior to sling removal and at 3
months postoperatively. Additionally, all women were
asked to estimate their general satisfaction regarding their
continence situation using a Visual Analogue Scale (VAS)
from 0 to 10, with 0 being the least satisfying situation and
10 being the most satisfying situation. All patients under-
went gynaecological examination including ICS-pelvic
organ prolapse staging (ICS-POP score).
Results Of the 18 slings, ten were transobturator tapes (6
9 TVT-O, 2 9 Monarch, 2 9 unknown) and eight were
retropubic tapes (7 9 TVT, 1 9 SPARC). Desire, arousal,
lubrication, satisfaction, and pain improved statistically
significant. Orgasm scores were low with median scoring
of 1.5 scores before and 1.0 scores after sling removal, and
they did not change significantly after sling removal. The
satisfaction rate deteriorated from a median of 7 (95%
confidence interval [CI] 6.3–7.7) to a median of 4 (95% CI
3.7–5.1; p = 0.99) but not statistically significant.
Conclusions Sexual function in patients with de novo
dyspareuina is likely to improve after sling removal but not
in all domains. Bladder function may deteriorate.
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The insertion of tension-free vaginal tapes was first
reported in 1996 for the treatment of female urinary
incontinence [1]. A polypropylene tape is placed transva-
ginally supporting the mid-urethra with no fixation.
Inserting a permanent tape below the mid-urethra might
affect sexual function and response, particularly if the tape
were too tight or were to erode the vagina.
The impact on sexual function has received little
attention in the medical literature for long time. The ‘‘G-
spot’’ is a supersensitive area for some women on the
anterior vaginal wall, the exact site differing among
women [2]. Because of the site of insertion of the perma-
nent tension free vaginal tape (TVT) the G spot might be
affected or the tape might be felt by the male partner and
might interfere with arousal and sensory stimulation.
Recent studies have reported varying degrees of sexual
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impairment after TVT insertion ranging from 0% to 15%,
including dyspareunia and loss of libido [3–5].
Occasionally, postoperative dyspareunia due to sling
insertion leads to request for sling removal despite the
patient being continent and otherwise satisfied.
The Female Sexual Function Index (FSFI) is a brief,
self-report measure of female function, which evaluates six
different domains of sexual function, including desire,
subjective arousal, lubrication, orgasm, satisfaction, and
pain. It was first described by Rosen in 2000 [6] and is
widely used for the assessment of sexual function.
The aim of this study was to evaluate sexual function
before and after suburethral sling removal due to postop-
erative female de novo dyspareunia. Additionally, patients’
general satisfaction with their overall continence situation
was assessed.
Patients and methods
This study was performed in the Department of Gynae-
cology, Inselspital Bern.
Ethical consent was obtained from the local ethics com-
mittee (KEK Bern, registration number 08–10-2007), and
patients gave written consent to participate in this study.
Between December 2005 and December 2007, we inclu-
ded all female patients who complained of de novo
dyspareunia after suburethral sling insertion for urinary
stress incontinence. Exclusion criteria were inability to
communicate in one of the local languages or English and/or
unwillingness or inability to fill in the FSFI questionnaire.
All patients filled in an FSFI questionnaire prior to sling
removal and at 3 months postoperatively. Additionally, all
women were asked to estimate their general satisfaction
regarding their continence situation using a visual analogue
scale (VAS) from 0 to 10, with 0 being the least satisfying
situation and 10 being the most satisfying situation.
All women underwent gynaecological examination
including ICS-pelvic organ prolapse staging (ICS-POP
Score), urine dipstick, multichannel urodynamics including
filling cystometry, pressure-flow studies, urethral profilom-
etry and perineal sonography prior to and 3 months after sling
removal and all patients had tried various therapies including
local oestrogen treatment, local anaesthetic topical ointment,
and pain medications before considering sling removal.
Removal was performed using median colpotomy under
regional or general anaesthetic according to the patients’
request. The sling was identified and the suburethral part
was removed by sharp dissection up to the lateral sulci
under careful visual control of the suburethral tissue to
avoid urethral injury. Excessive scar tissue was removed
and the vaginal epithelium was sutured using Vicryl 2-0
interrupted sutures.
Results
Eighteen patients could be included in the study. Mean
patient age was 53 years (range 32–67) years, median Body
Mass Index (BMI) was 28 kg/m2 (range 24–36 kg/m2),
median parity was 2 (range 0–4) and median time interval
between original sling insertion and removal was 8 months
(range 4–10 months). Median operating time was 15 min
(range 10–40 min). Estimated median blood loss was 20 ml
(range 10–50 ml).
All patients were sexually active, with 17 in a hetero-
sexual relationship and one in a homosexual relationship.
All of them complained of dyspareunia with an onset
after suburethral sling insertion for urodynamic stress
incontinence.
There was no tape erosion or poor healing except for one
case of a patient with excessive suburethral scar tissue
(5.6%).
In this woman, additionally to female dyspareunia the
male partner suffered from dyspareunia and had injured the
penile frenulum at the first attempt of sexual intercourse,
resulting in major bleeding. In that case, the sling went
through the vagina dividing it into an upper and a lower
space like a hammock.
Of the 18 slings, ten were transobturator tapes (6 9
TVT-O, 2 9 Monarch, 2 9 unknown) and eight were
retropubic tapes (7 9 TVT, 1 9 SPARC).
In the past, seven patients had had an anterior repair, nine
patients a hysterectomy, of whom five had a vaginal hys-
terectomy, three a laparoscopic hysterectomy, and one an
open abdominal hysterectomy for benign reasons. All these
patients had had these operations prior to sling insertion.
None of the patients had a significant pelvic organ prolapse
of more than stage I at the time of sling removal.
Two patients were on systemic hormone-replacement
therapy (HRT) and 14 patients were on topical estrogens at
the time of sling removal.
In three patients, stress incontinence reoccurred after
sling removal.
Figure 1 shows the results of the FSFI questionnaire
before and after sling removal. The domain qualities are
marked in the same color, with the left column expressing
scores before removal and the right column after sling
removal.
Desire (p\0.0001), arousal (p\0.0001), lubrication (p
\0.0006), satisfaction (p = 0.029), and pain (p\0.0001)
improved statistically significant.
Orgasm scores were low with median scoring of 1.5
scores before and 1.0 scores after sling removal and did not
change significantly after sling removal (p = 0.82; all two-
tailed t-test).
Figure 2 shows the patients’ satisfaction with their
bladder condition expressed by VAS.
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The satisfaction rate deteriorated from a median of 7
(95% CI 6.3–7.7) to a median of 4 (95% CI 3.7–5.1;
p = 0.99) but not statistically significantly.
Management
Of the three patients with recurrent stress incontinence,
we performed Burch colposuspension in one patient suc-
cessfully. One patient had a transurethral bladder neck
injection as the bladder neck remained immobile after
sling removal.
One patient was reluctant to have any further surgery
performed and is currently referred to conservative therapy
with pessary and pelvic floor exercises.
Discussion
It is difficult to estimate the percentage of women requiring
sling removal based on the current study as 94% of our
patients were referred from other surgeons after the post-
operative dyspareunia had arisen. Only one patient was
from our clinic; we insert approximately 60 slings per year
and have paid attention to sexual function for the past 2
years. Calculations based on these numbers indicate that
we have a dyspareunia rate of 1.7% requiring sling
removal; however, as this question was not investigated in
this study, this is an estimation only. Karram [7] reports
0.9% poor healing at the site of the vaginal incision in
his study of 350 patients undergoing sling insertion, and
4.9% voiding dysfunction and 0.5% of patients requiring
another incontinence procedure for recurrent or persisting
incontinence.
We cannot be sure why dyspareunia occurred after sling
insertion; the literature is contradictory regarding the
influence of continence surgery on sexuality.
Impairment of sexual life by urinary incontinence itself
has been described without surgery in 30% of women [8].
Generally, sexual function may be impaired after surgery
for stress urinary incontinence. Cayan [9] found that Burch
colposuspension deteriorated sexual function much more
than vaginal surgery in women, but impact in the vaginal
group was evident as well. Shah [10] was unable to show
deterioration of sexual function in a series of 29 patients
who underwent polypropylene sling insertion for urinary
stress incontinence.
The current study shows an improvement of sexual
function after suburethral sling removal for dyspareunia in
the domains of desire, arousal, lubrication, satisfaction, and
particularly pain.
The orgasm domain remained unchanged, with a low
scoring prior to intervention. We cannot be sure if this
finding is directly related to sling insertion as patients had
additional gynaecologic surgery in the past: 50% had had
hysterectomy for benign reasons and 35% an anterior
colporrhaphy.
Reports on the impact of hysterectomy on sexual
function have been conflicting, with some evidence of
improvement after hysterectomy [11, 12] but also of sexual
impairment [13].
Similarly, some investigators have reported that the
surgical management of pelvic organ prolapse improves
sexual function in the patients [14]. However, this positive
effect of treatment has not been confirmed by all
researchers [15, 16]. A pre-existing alteration of sexual
function due to anterior repair is possible. Anterior repair
may cause scarring of the anterior vaginal wall and subu-
rethral area and may contribute to a loss of physiological
Fig. 1 FSFI domains before and after sling removal
Fig. 2 Patients’ satisfaction with their bladder condition before and
after sling removal
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sexuality. We have no information on sexual function prior
to sling insertion, which is a weakness of the study.
One strength of this study is its prospective design and
the use of validated tools. In this study, we used the
translated standardized FSFI questionnaire, which is
designed according to the three-phase model of female
sexual response described by Kaplan [6]. Unfortunately, a
translated validated version of FSFI was not available at
the time of the study.
Recurrence of stress incontinence is a known risk after
sling removal [17]. In our study, 15% of patients experi-
enced recurrence of stress incontinence, which is probably
the reason why patients’ overall satisfaction with their
bladder condition dropped by three points using the VAS,
which is a validated tool to assess patients’ perception
[15–17].
Considering the route of sling insertion, there is some
evidence that transobturator tapes cause more dyspareunia
than classical retropubic tapes with 7–10% for the tran-
sobturator route [18, 19] and 1–3.3% for retropubic tapes
[20, 21]. In our study, both surgical routes were almost
equally represented, with ten transobturator tapes and eight
retropubic slings. Randomized trials with sufficient power
to determine which route is best regarding sexual function
are missing. It is advisable to inform the patient before any
sling insertion that dyspareunia may occur.
As for the male injury, there is no Medline literature to
compare with. Male dyspareunia may be due to anatomical
reasons such as balanitis or a short frenulum [22, 23] but
we did not examine the male partner of our patient.
However, with the sling being placed through the mid-
vaginal opening it is indeed unlikely to be caused by the
male anatomy but by the wrongly placed sling.
In conclusion, if de novo dyspareunia after sling inser-
tion occurs and conservative therapy including topical
oestrogen application, lubricants, and sometimes even pain
medication fails, suburethral sling removal needs to be
discussed. We can reassure the patient that sexual function
is likely to improve but not in all domains.
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